Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Stem cell therapy independent of stemness.
Anti-IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in CR-EAE ABH Mice.
Difficulties with emotion regulation in multiple sclerosis: Links to executive function, mood, and quality of life.
Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Linking synaptopathy and gray matter damage in multiple sclerosis.
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions.
Embryonic stem cells in multiple sclerosis.
B-59Comprehensive Examination of Factors Contributing to Employment Status in Multiple Sclerosis.
Restless legs syndrome in Iranian patients with multiple sclerosis.
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.
The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Risk evaluation and monitoring in multiple sclerosis therapeutics.
[Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
Health-related quality of life among latinos with multiple sclerosis.
Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis.
Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis.
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population.
PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [(11)C]MeDAS, [ (11)C]CIC and [ (11)C]PIB.
Eight-and-a-half syndrome as presenting sign of childhood multiple sclerosis.
Pages
« first
‹ previous
…
407
408
409
410
411
412
413
414
415
…
next ›
last »